USANA HEALTH SCIENCES INC (USNA): M&A transaction — USANA acquires 78.8% stake in Hiya Health for $205M; Hiya had $103M sales, $22M adjusted EBITDA LTM

USANA HEALTH SCIENCES INC

Acquired 78.8% controlling stake in Hiya Health for $205M cash; closed Dec 23, 2024.
Hiya's LTM (Sept 30, 2024) net sales $103M, net income $19M, adjusted EBITDA $22M.
Hiya serves 200,000+ customers via DTC subscription; net sales grew 50% in 2024 vs 2023.
Transaction expected to be immediately accretive to USANA's 2025 adjusted EBITDA.
Remaining 21.15% rollover equity subject to put/call based on Hiya's future EBITDA; financed from $200M cash on hand and credit facility.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

USANA HEALTH SCIENCES INC completed an acquisition involving Hiya Health Products, LLC for $205 million in cash (closed 2024-12-23).

Action: acquisition
Counterparty: Hiya Health Products, LLC
Consideration: $205 million in cash
Closing: 2024-12-23

Exact text from the filing

and delivery of an option termination agreement by such holders. The total consideration paid by USANA for its 78.85% membership interest in the Surviving Company consisted of $205 million in cash, subject to customary closing and post-closing purchase price adjustments in accordance with and subject to the terms and conditions of the Merger Agreement, sourced from

View on SEC.gov

Browse all m&a transactions →

USANA HEALTH SCIENCES INC filing history →

Source: SEC EDGAR

accession 0000896264-24-000235

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.